Insmed | INSM - Eps Utile Per Azione

Prezzo Delle Azioni
163.81
Cambio Giornaliero
1.38 0.85%
Mensile
14.45%
Annuale
140.58%
Q2 Previsione
157.54

Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q1 Mar/2026 -0.99 -1.42 Apr/30
FY2025Q4 Dec/2025 -1.54 -1.28 -1.32 Feb/19
FY2025Q3 Sep/2025 -1.75 -1.34 -1.27 Oct/30
FY2025Q2 Jun/2025 -1.70 -1.36 -1.94 Aug/07
FY2025Q1 Mar/2025 -1.42 -1.20 -1.06 May/08




Eps Cambiamento Data
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Cytokinetics USD -1.5 1.05 2025-12
DBV Technologies USD -0.24 1.31 2025-09
Gilead Sciences USD 1.86 0.61 2025-12
Heron Therapeutics USD -0.02 0.02 2025-12
Insmed USD -1.54 0.21 2025-12
Novartis USD 1.54 0.48 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12